The Artificial Intelligence in Diabetes Management report delivers comprehensive analysis of the market by providing information on the number of companies engaged in various segments of the Artificial Intelligence in Diabetes Management economy. Apart from exploring the key trends driving the market, the report discusses the most interesting case studies about the market including the overview of the future market development in the forecast period 2021-2028.
Key players profiled in the report includes:
Abbott Laboratories, Bigfoot Biomedical, Inc., Cardinal Health Inc., Crayon Group, Diabnext, DreaMed Diabetes, Ltd., Eyenuk, Inc., F. Hoffmann-La Roche Ltd, HCL Technologies Limited, IBM Corporation, Karger AG, Medtronic PLC, Nasdaq Inc, Novartis AG, Novo Nordisk A/S, Sanofi SA, Virta Health Corp.